Nav: Home

New study identifies genetic variant that could help reduce need for liver transplants

April 02, 2019

A new study from The Westmead Institute for Medical Research has identified a genetic variant associated with liver fibrosis (scarring) in chronic hepatitis C patients. This finding is a step toward reducing the number of patients requiring liver transplants.

Researchers studied the role and mechanisms of a genetic variation in the MICA gene, a gene that is induced when cells are damaged.

The research team were able to show that, in 1,689 patients with chronic hepatitis C, the MICA gene variant rs2596542 is associated with the progression and severity of liver fibrosis.

They believe this occurs because rs2596542 triggers an immune response that increases the rate of liver fibrosis in patients with chronic hepatitis C infection.

First author of the study, Dr Rasha El Sharkawy said, "Understanding how and why liver fibrosis occurs is crucial for preventing health complications in those at risk.

"Chronic hepatitis C, liver fibrosis and hepatocellular carcinoma (or HCC - the most common form of primary liver cancer) are all serious conditions that are closely linked.

"Chronic hepatitis C is a major risk factor for liver cirrhosis (advanced liver fibrosis), and a leading cause of HCC in Australia. Liver scarring and chronic hepatitis C are both conditions that can lead to a liver transplant.

"The rate of fibrosis differs from person to person, so understanding the genetics behind liver fibrosis is critical for prevention.

"Now that we have identified a genetic variant associated with liver fibrosis in people with chronic hepatitis C, we can work towards targeting this variant to identify which patients are at greater risk of developing liver fibrosis, as well as creating better preventative measures and new treatments."

Currently, there are no approved treatments to reduce fibrosis in the liver. Liver transplantation is the only 'cure' for those with end-stage liver disease.

"Each year an estimated 339,000 people die globally from hepatitis C, mostly from cirrhosis and HCC," Dr El Sharkawy said.

"While some patients are eligible for a liver transplant to 'treat' complications, there are far more patients than there are donors, and not all patients are suitable for a transplant.

"Preventing the progression of fibrosis could reduce the number of patients who require a liver transplant.

"By identifying which patients are at a greater risk of fibrosis, we can potentially prevent complications of fibrosis before they occur.

"We can now also investigate the risk variant as a potential target for future treatments, reducing the overall number of patients living with liver complications."

The research paper was published in Scientific Reports:
The research was led by Professor Jacob George and Associate Professor Mohammed Eslam.

Dr Rasha El Sharkawy is affiliated with The Westmead Institute for Medical Research and the University of Sydney.

Professor Jacob George is affiliated with The Westmead Institute for Medical Research, the University of Sydney and Westmead Hospital.

Associate Professor Mohammed Eslam is associated with The Westmead Institute for Medical Research and the University of Sydney.

Westmead Institute for Medical Research

Related Hepatitis Articles:

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.
Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.
How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.
New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.
High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.
More Hepatitis News and Hepatitis Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...